Path Foundation, Inc. – Trademark Portfolio
Entity Type: 03
Path Foundation, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PATH FOUNDATION, CELL COMMAND THERAPY, and THE SILVER COMET TRAIL. The owner is based in Atlanta, GA.
1601 W. Peachtree Street
Atlanta, GA 30309
Showing of trademarks Trademarks
Trademark Classifications
Path Foundation, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Path Foundation, Inc. have?
Path Foundation, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Path Foundation, Inc. file in?
Path Foundation, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 25 (Clothing). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Path Foundation, Inc.'s most well-known trademarks?
Path Foundation, Inc.'s registered trademark portfolio includes well-known marks such as PATH FOUNDATION, CELL COMMAND THERAPY, and THE SILVER COMET TRAIL. These are among 3 currently registered trademarks in the portfolio.
What is Path Foundation, Inc.'s trademark registration success rate?
Path Foundation, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.